MindWalk Holdings (HYFT) Interest & Investment Income (2023 - 2025)
MindWalk Holdings (HYFT) posted quarterly Interest & Investment Income of $3.6 million for Q3 2025, up 349.14% year-over-year from $810207.6 in Q3 2024, and up 349.14% quarter-over-quarter from -$1.5 million in Q3 2024.
MindWalk Holdings (HYFT) Interest & Investment Income (2023 - 2025) Analysis & Trends
MindWalk Holdings (HYFT) has reported Interest & Investment Income for 3 consecutive years, with $3.6 million the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | 36.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 3.64 Mn |
| Jul 31, 2024 | -1.46 Mn |
| Jul 31, 2023 | 5.99 Mn |